CHRM3 and cancer: In mice, functional M3R deficiency, whether achieved by ablating Chrm3 or more recently by selective M3R antagonism, reduces tumor number and attenuates cancer cell invasion (Raufman et al., 2008, 2011; Hering et al., 2021).